Intravenous immunoglobulin does not reduce left ventricular remodeling in patients with myocardial dysfunction during hospitalization after acute myocardial infarction.

@article{Gullestad2013IntravenousID,
  title={Intravenous immunoglobulin does not reduce left ventricular remodeling in patients with myocardial dysfunction during hospitalization after acute myocardial infarction.},
  author={Lars Gullestad and Stein Orn and Kenneth Dickstein and Christian H Eek and Thor Edvardsen and Svend Aakhus and Erik Tandberg Askevold and Annika Elisabet Michelsen and Bj{\o}rn Bendz and Rita Sk{\aa}rdal and Howard Smith and Arne Yndestad and Thor Ueland and P{\aa}l Aukrust},
  journal={International journal of cardiology},
  year={2013},
  volume={168 1},
  pages={
          212-8
        }
}
BACKGROUND Left ventricular (LV) remodeling takes place after acute myocardial infarction (MI), potentially leading to overt heart failure (HF). Enhanced inflammation may contribute to LV remodeling. Our hypothesis was that the immunomodulating effects of intravenous immunoglobulin (IVIg) would be beneficial in patients with impaired myocardial function after MI by reducing myocardial remodeling and improving myocardial function. METHODS Sixty-two patients with acute MI treated by… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 30 REFERENCES

Anti-inflammatory Agents: Present and Future

VIEW 15 EXCERPTS
HIGHLY INFLUENTIAL

C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction

S Orn, C Manhenke, T Ueland
  • Eur Heart J 2009;30:1180-6
  • 2009
VIEW 1 EXCERPT
HIGHLY INFLUENTIAL